Application Information

This drug has been submitted to the FDA under the reference 040253/001.

Names and composition

"ETHOSUXIMIDE" is the commercial name of a drug composed of ETHOSUXIMIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
040253/001 ETHOSUXIMIDE ETHOSUXIMIDE SYRUP/ORAL 250MG per 5ML
040430/001 ETHOSUXIMIDE ETHOSUXIMIDE CAPSULE/ORAL 250MG
040506/001 ETHOSUXIMIDE ETHOSUXIMIDE SYRUP/ORAL 250MG per 5ML
040686/001 ETHOSUXIMIDE ETHOSUXIMIDE CAPSULE/ORAL 250MG
081306/001 ETHOSUXIMIDE ETHOSUXIMIDE SYRUP/ORAL 250MG per 5ML
200892/001 ETHOSUXIMIDE ETHOSUXIMIDE CAPSULE/ORAL 250MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
012380/001 ZARONTIN ETHOSUXIMIDE CAPSULE/ORAL 250MG
040253/001 ETHOSUXIMIDE ETHOSUXIMIDE SYRUP/ORAL 250MG per 5ML
040430/001 ETHOSUXIMIDE ETHOSUXIMIDE CAPSULE/ORAL 250MG
040506/001 ETHOSUXIMIDE ETHOSUXIMIDE SYRUP/ORAL 250MG per 5ML
040686/001 ETHOSUXIMIDE ETHOSUXIMIDE CAPSULE/ORAL 250MG
080258/001 ZARONTIN ETHOSUXIMIDE SYRUP/ORAL 250MG per 5ML
081306/001 ETHOSUXIMIDE ETHOSUXIMIDE SYRUP/ORAL 250MG per 5ML
200892/001 ETHOSUXIMIDE ETHOSUXIMIDE CAPSULE/ORAL 250MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved